The purpose of this preliminary study was to evaluate the relationship between a possible biochemical marker of stress, 24-h urinary concentrations of Corticotropin Releasing Factor-Like Immunoreactivity (CRF-LI), and ratings of stress-related symptoms like depression and anxiety, as well as to evaluate pain and emotional reactions in patients with fibromyalgia (FM). Another purpose was to study the effects of massage and guided relaxation, with respect to change in the same variables. Urine sampling and ratings were performed before treatments, after and 1 month after completed treatments. Concentrations of CRF-LI was analysed with radioimmnoassay technique. For the assessment of depression, anxiety and pain the CPRS-A questionnaire was used and for rated pain and emotional reactions the NHP questionnaire was used. The 24-h urinary concentration of the CRF-LI was found to be related to depression, mood and inability to take initiative. After treatment the urinary CRF-LI concentrations and the rated levels of pain and emotional reactions were found to have decreased. In conclusion, the 24-h urinary CRF-LI concentration may be used as a biochemical marker of stress-related symptoms such as depression in patients with FM and possibly also other conditions characterized by chronic pain. Therapies such as massage and guided relaxation may be tried for the amelioration of pain and stress but further studies are required. © 2006 Elsevier Ireland Ltd. All rights reserved.
CNS, is known as a key physiological mediator of the endocrine, autonomic, and behavioural responses to stress [2] [3] [4] . Elevated plasma and cerebrospinal fluid (CSF) concentrations of CRF have been found in patients with FM [27] and, in patients with posttraumatic stress disorder [6] . It has therefore been suggested that hyperactive CRF neurons play a role in the nociceptive and psychological mechanisms in FM [7, 23, 24, 27] . The central autonomic control of stress is complex and not possible to assess by a single test so a variety of techniques have been tried out [26] . CRF concentration is usually measured in CSF, which is a procedure that may be stressful. A possible alternative for analysis of CRF concentration could be urinary sampling. Furthermore, by analyzing 24-h urinary samples, the influence of diurnal variation could be diminished.
Conventional medicine has generally been reported as ineffective in the treatment of FM [19] and stepwise rehabilita-tion programs have been recommended [13, 21] . Despite lack of strong evidence for the use of non-pharmacological interventions in FM [28] , different modes of sensory stimulation like massage, relaxation therapies and acupuncture have gained increasing popularity. Massage has been reported to reduce pain, depression and anxiety in patients with FM [1, 5, 9] . Hypothetically, stimulation of mechanical receptors in the skin and deeper tissues during massage or psychologically induced interventions may alter the functions of limbic structures of the brain, leading to a reduction in pain and stress-like symptoms changes that possibly are reflected in reduced concentrations of Corticotropin Releasing Factor-Like Immunoreactivity, CRF-LI, in 24-h urine samples.
The aim of this study was to examine the measured concentrations of 24-h urinary CRF-LI and their possible relationship to rated stress-related symptoms like depression and anxiety as well as to evaluate rated pain and emotional reactions in patients with fibromyalgia. A secondary aim was to evaluate the changes in assessed variables in response to a treatment period of massage and guided relaxation.
Patients fulfilling the criteria for fibromyalgia according to the American College of Rheumatology (ACR) [35] , and enrolled in an outpatient fibromyalgia course at the Rehabilitation Medicine Clinic at Karolinska University Hospital were invited to participate. All the patients were medically examined and a kidney function test was included in the examination. The patients were asked not to start any new interventions but were allowed to continue ongoing treatment and medication. The experiments were conducted in accordance with the declaration of Helsinki and before participating in the study, the patients gave their informed consent. In total 59 patients were asked to participate out of which 47 replied, and 19 finally consented. The Ethic Committee of Karolinska University Hospital approved the study, dnr 99-223.
Data collection of urine samples, recorded ratings, and measurements of blood pressure and heart rate frequency were performed just prior to the treatment period, after the 6 weeks of treatments, and 1 month after completed treatment period. After collecting the data prior to treatment, the patients were randomly assigned to massage or guided relaxation. Sealed envelopes containing labels with treatment allocation were the means for the randomization procedure.
The urine samples were collected in plastic boxes, containing 6 M hydrochloric acid, during 24 h. The individual total urine volume was mixed, measured, and a sample of 50 mL was stored at −70 • C. Prior to analysis each urine sample was filtrated and additionally acidified with 50 L of 10% trifluoraceticacid, TFA. For the urinary purifying process a cartridge was used (Sep-Pak ® C 18 Water Assoc. Inc., Milford, MA, USA), that was prepared with 10 mL of methanol containing 0.1% of TFA, followed by 10 mL H 2 O with 0.1% TFA. After application of the urine sample, the cartridge was rinsed with 2 mL of H 2 O with 0.1% TFA and the sample was finally eluted by 4 mL of methanol with 0.1% of TFA. The sample was then vacuum-dried and stored at +4 • C. When analysed, each vacuum-dried sample was dissolved in 1 mL phosphate buffer (0.05 M, 1.0% BSA, pH 7.4) and a standard curve was prepared. For the RIA analysis RAB-019-06 CRF antiserum (Phoenix Pharmaceuticals Inc, USA) was used. One hundred microliters of antiserum was incubated with 100 L of standard solution or the purified sample at +4 • C for 48 h. One hundred microliters of [ 125 I] tracer solution (Eurodiagnostica, Malmö, Sweden), was then added to the sample and incubated at +4 • C for 24 h. For separation of the bound from the unbound fraction in the sample, 500 L of a second antibody, Decanting Suspension 3 (Pharmacia & Upjohn Diagnostics, Uppsala, Sweden) was added and incubated for 30 min in room temperature. By adding 1.0 mL water to each sample this reaction was stopped. After centrifugation in 15 min at +4 • C (2800 × g), the supernatant was poured off and the activity of the isotope [ 125 I] in the precipitate was measured for 3 min per sample in a gamma counter (Wizard 1470, Wallac, Turku, Finland). The detection limits for CRF in each test sample were 3.9 and 1000 pmol/L. The cross reactivity was 100% to CRF (human, rat); 0% to ACTH (human), 0% to LH-RH, 0% to PACAP-38 (human, rat, ovine), 0% to [Arg8]-vasopressin, 0% to urocortin (human), 0% to urocortin (rat), 0% to BNP-45 (rat). All samples in the analysis were made in duplicate and the 24-h CRF-LI concentration was calculated for each individual relative the filtered and the total urine volume.
All women completed a questionnaire, covering demographic data, Table 1 .
A Comprehensive Psychopathological Rating ScaleAffective, CPRS-A [29] , modified for patients with pain and used at the Karolinska University Hospital was used. The questionnaire contains 22 items designed to assess symptoms of depression and anxiety symptoms including pain and ache. The seven response alternatives are graded from 0 to 3 (in steps of 0.5). The higher the response value, the higher level of distress was assessed.
The Swedish version of the Nottingham Health Profile (NHP) questionnaire was used for the assessment of pain and emotional reactions [34] . The NHP variables are assessed by agreement (yes, no) to statements concerning complaints. Eight statements concern the variable pain, and nine the variable emotional reaction. The numbers of agreed statements are operationally defined as the levels of perceived pain and emotional reaction, respectively. Hence, the level of pain is scored from 0 (no indication of pain) to 8 (all indicators of pain were chosen), and correspondingly the level of emotional reaction is scored from 0 to 9.
Heart rate frequency and blood pressure were measured before every treatment by radial pulse palpation and by using a standard cuff technique in the patients after they had been lying down for 10 min.
Twelve treatments of either massage or guided relaxation, lasting for 30 min each, were given twice weekly for 6 weeks. During the treatments the patients were lying down in a back and/or prone position. Soft standardized music at low volume was used in order to mute stressful feelings and background. The massage treatment was applied to different body areas (feet and legs 18 min, hands and arms 8 min, face 4 min) and consisted of the standardized massage techniques stroking (effleurage), kneading (petrissage), friction, and shaking-all performed in a slow rate of approximately 1 Hz. The hand pressure was always adjusted according to the patients' preference. Massage lotion (CCN, Stockholm, Sweden) or massage oil (Rolf Kullgren AB, Stockholm, Sweden) was used to diminish friction of the skinto-skin contact during massage treatment. The patients assigned to relaxation therapy were personally guided into progressive relaxation according to Jacobsen [20] . The mean and S.D. was used to describe age. The median and range was used to calculate the duration of fibromyalgia and selfrated outcome variables. The distribution of datasets and relation between variables were described as plots. A possible relationship between the CRF-LI concentrations and the ratings of the modified CPRS-A instrument was described by the Spearman rank order correlation coefficient (r s ). The Wilcoxon signed rank test was used for the evaluation of change in CRF-LI concentrations in response to treatment and the hypothesis of no change of rated variables in response to treatment was tested with sign test. The levels of change in the variables assessed by the CPRS-A and NHP were described by square contingency tables and evidences of systematic group change and additional individual changes were evaluated according to Svensson [30] . The ranking approach by Svensson makes it possible to evaluate the level of change that is in common for the group separately from additional individual changes. A systematic change in the level of complains between the assessments before and after treatments appears as different marginal distributions of data on the two occasions, which means marginal heterogeneity in the contingency tables. The level of systematic change in position of scale assessments between two occasions, denoted X and Y, expressed as the relative position, RP, is defined by the difference between the probabilities P(X < Y) − P(Y < X), and is estimated by the relative frequencies of the marginal assessments after treatment being to higher categories than before treatment (X < Y) and to lower categories (Y < X), respectively. Possible values of RP range from -1 to 1. A positive RP value indicates that the group, as a whole, have assessed a higher level of rated complaint after treatment compared with the assessments before treatment. The level of systematic change in complaints refers to a common group change, but often there is heterogeneity in the pattern of changes after treatment. A presence of such an individual variation in change, unexplained by the RP value of systematic change in position, is evident from dispersed observations in the contingency table. By transforming the individual pairs of data to pairs of ranks that are tied on the pairs, it is possible to calculate the level of individual variations in change separately from the level of systematic change. The measure is called the Relative Rank Variance, RV, ranging from 0 to 1. The higher the values of RV, the more dispersed are the observations. The evaluation of the systematic changes reflects the treatment efficacy on the entire group. Strong evidences of additional individual changes, high RV values, indicate that individually designed interventions would be preferable. For more information, see [31] . A two-side p-value less than 0.05 was regarded as significant. The software package SYSRAN 1.0 for Matlab 6 was used to calculate the measures of RP and RV, and their corresponding 95% confidence intervals, CI. Moreover, STATISTICA 7.0 was used.
The mean age of the participating women were, n = 19, was 50.7 (S.D. 9.7) years and the median duration time of fibromyalgia was 14 (range, 3-42) years. Demographic data and clinical characteristics are shown in Table 1 . Ten of the patients were randomized to massage and nine to guided relaxation. Fig. 1a-c show the observed relationships between the urinary CRF-LI concentrations and rated levels of depression, r s = 0.47 (n = 18, p = 0.05), mood, r s = 0.57 (n = 18, p = 0.01), and ability to take an initiative, r s = 0.58 (n = 18, p = 0.01). Furthermore, r s = 0.33 (n = 18, p = 0.19) was observed between CRF-LI and anxiety.
Three of the patients randomized to guided relaxation dropped out due to the patient's perceived lack of time for treatment sessions but also to their own capability of performing the relaxation exercises at by themselves at home. The remaining 16 patients were included in the analysis of rated variables regarding treatment effects. Two of the patients assigned to the guided relaxation failed to deliver their urine samples. Due to small number of individuals, the guided relaxation group was excluded from analysis of the treatment effects on urinary CRF-LI concentrations. Fig. 1. (a-c) Relationship between 24-h urinary CRF-LI concentrations and rated depression (a), mood (b), and ability to take initiative (c) according to the CPRS-A questionnaire. One urine sample was excluded from analysis due to undetectable activity, n = 18.
In the massage group, the median changes in CRF-LI concentrations after treatments was 0.51 pmol/L (n = 10, T = 3.00; p = 0.01) and 0.61 pmol/L (n = 7, T = 5.00; p = 0.13), 1 month after completed treatments, Fig. 2 .
As evident from the pairs of observations in Fig. 3a , 10 of 16 women (seven massage) rated their perceived pain and ache lower after treatments and 8 of 16 women (five massage) 1 month after completed treatments, Fig. 3b . The non-zero RP value RP −0.64 (95% CI −0.94 to −0.34) indicate that the observed decrease in pain and ache after massage is a systematic group change, p = 0.02, though an individual variation was present RV 0.22 (95% CI 0.00-0.53). The group change was not that pronounced 1 month after massage, RP −0.44 (95% CI −0.84 to −0.04), p = 0.22, and the additional individual variation was even greater RV 0.34 (95% CI 0.00-0. 0.80). Corresponding results in the small guided relaxation group, n = 6, were RP −0.33 (95% CI −0.91 to −0.25) and RP −0.28 (95% CI −0.93 to −0.37). Additional individual variations were also here present, RV 0.06 (95% CI 0.00-0.25) and RV 0.22 (95% CI 0.00-0.63), respectively.
After the treatment period, less indications of pain according to the NHP questionnaire were reported in 4 (one massage) of 16 women and 1 month after completed treatment in 6 (four massage) of 16 women, RP −0.28 (95% CI −0.53 to −0.03). Also, fewer indications of emotional reaction were reported after Fig. 2 . Change of 24-h urinary CRF-LI concentrations in response to massage. Before-after treatments, n = 10. Before-1 month after completed treatments, n = 7. Three samples were excluded from analysis due to undetectable activity. No changes were seen in either treatment group after the treatment period in the measured heart rate frequency (mean change; massage -4 beats/min; guided relaxation 4 beats/min), and systolic blood pressure (mean change; massage 1.86 mmHg; guided relaxation 5.83 mmHg).
In this study a 24-h urine sampling procedure was chosen to allow quantification of CRF-LI concentration representing stress level and the function of the HPA-axis across the diurnal cycle. The relationship found between the 24-h urine CRF-LI concentrations and the rated level of depression, mood and, ability to take initiative may indicate that urinary CRF-LI concentration could be used as a biochemical marker of perceived stress-related symptoms, like depression, in patients suffering from fibromyalgia. Possibly it could also serve as a biochemical marker for other painful conditions than fibromyalgia since depression may be an integral part of long-lasting pain [22] .
Despite the limited number of individuals some interesting evidences of treatment effects were found. After 6 weeks of massage treatments twice a week, the 24-h urinary concentrations of CRF-LI were decreased as were the rated pain and emotional reaction. In the group receiving guided relaxation a similar pattern of emotional reactions was seen.
The effects of massage were sustained for 1 month after but with larger individual variations suggesting that long-term effects of improvement may be obtained. This finding is supported by a recent study reporting amelioration of pain, depression and anxiety 3 months after a treatment period of Swedish massage [33] . Also, in a study by Hanley and collaborators [17] , a decrease of stress was seen in response to treatments of massage or listening to a relaxation tape. It has been suggested that anti-depressants induce an increase of glucocorticoid receptors in the HPA-axis resulting in a re-establishment of the function of the HPA-system [4] but the mechanism for massage and relaxation therapies affecting the stress-related symptoms needs further research.
Variability of the results, such as overlapping of the CRF-LI concentration compared to the positions on the CPRS-A rating scale, could be due to various factors such as that patients diagnosed as suffering from fibromyalgia are a heterogeneous group [11] . Distinct subgroups of patients with fibromyalgia have been identified by assessing pressure pain thresholds, mood and cognitive factors [11, 14] . The existence of subgroups in fibromyalgia is also supported by Thieme et al. [32] who reported varying proportions of co morbid anxiety and depression dependent on psychosocial characteristics of the patients. In the present results the responses to treatment demonstrated individual variations confirmed by the measure of RV. This may indicate that individual responses should be taken into consideration for instance in determining number of treatments for optimal results. Possibly sensory stimulation techniques may influence subgroups of fibromyalgia affected by the presence of depression differently. Interestingly, Finset and collaborators [10] , suggest that depression may serve as a predictive factor for treatment response. Beside the low number of participating patients, the possible contribution of different stages of the hormonal cycle as well as postmenopausal effects has not been taken into consideration.
In conclusion, the 24-h urinary CRF-LI concentration may be used as a biochemical marker of stress-related symptoms like depression in patients with FM and possibly also other conditions characterized by chronic pain. Therapies such as massage and guided relaxation may be tried for the amelioration of pain and stress but further studies are required.
